The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy

Background: Cardiovascular autonomic neuropathy (CAN) in type 2 diabetes mellitus (T2DM), which is characterized by lesion of nerve fibers in parasympathetic and sympathetic nervous system is one of the leading causes of heart arrhythmias and an independent risk factor for cardiovascular mortality i...

Full description

Bibliographic Details
Main Authors: Victoria A. Serhiyenko, Boris N. Mankovsky, Ludmila М. Serhiyenko, Aleksandr A. Serhiyenko
Format: Article
Language:English
Published: Endocrinology Research Centre 2019-04-01
Series:Сахарный диабет
Subjects:
Online Access:https://dia-endojournals.ru/dia/article/viewFile/9630/pdf
id doaj-c7f304c5495742ad8f98f5cc17c006c9
record_format Article
spelling doaj-c7f304c5495742ad8f98f5cc17c006c92021-06-02T19:26:20ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782019-04-01221626910.14341/DM96308644The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathyVictoria A. Serhiyenko0Boris N. Mankovsky1Ludmila М. Serhiyenko2Aleksandr A. Serhiyenko3Danylo Halitsky National Medical UniversityP.L. Shupik National Medical Academy of Postgraduate EducationDanylo Halitsky National Medical UniversityDanylo Halitsky National Medical UniversityBackground: Cardiovascular autonomic neuropathy (CAN) in type 2 diabetes mellitus (T2DM), which is characterized by lesion of nerve fibers in parasympathetic and sympathetic nervous system is one of the leading causes of heart arrhythmias and an independent risk factor for cardiovascular mortality in patients with T2DM. Therefore, the problem of effective treatment of CAN is particularly relevant. Aims: To analyze the effect of long-chain polyunsaturated fatty acids (-3 PUFAs) on ambulatory blood pressure monitoring parameters in patients with T2DM and CAN. Materials and methods: 36 patients with T2DM and confirmed CAN were divided into two groups. First group received hypoglycemic therapy (n=15, control) for three months; patients in group 2 (n=21) in addition were administered 1 capsule/q.d. of -3 PUFAs for three month. Results: Treatment with -3 PUFAs led to significant decrease of the diastolic blood pressure (DBP) (p0,01), diastolic blood pressure load (p0,05), time index of DBP (p0,05) during the day; DBP (p0,05), diastolic blood pressure load (p0,05), time index of DBP (p0,05), SD DBP (p0,01) during the night (compared to the control group). Conclusions: The study showed that prescription of -3 PUFAs for three month was effective in decreasing diastolic blood pressure and its parameters among patients with T2DM and CAN.https://dia-endojournals.ru/dia/article/viewFile/9630/pdfdiabetic cardiovascular autonomic neuropathypolyunsaturated fatty acidsambulatory blood pressure monitoring
collection DOAJ
language English
format Article
sources DOAJ
author Victoria A. Serhiyenko
Boris N. Mankovsky
Ludmila М. Serhiyenko
Aleksandr A. Serhiyenko
spellingShingle Victoria A. Serhiyenko
Boris N. Mankovsky
Ludmila М. Serhiyenko
Aleksandr A. Serhiyenko
The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy
Сахарный диабет
diabetic cardiovascular autonomic neuropathy
polyunsaturated fatty acids
ambulatory blood pressure monitoring
author_facet Victoria A. Serhiyenko
Boris N. Mankovsky
Ludmila М. Serhiyenko
Aleksandr A. Serhiyenko
author_sort Victoria A. Serhiyenko
title The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy
title_short The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy
title_full The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy
title_fullStr The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy
title_full_unstemmed The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy
title_sort effect of omega-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy
publisher Endocrinology Research Centre
series Сахарный диабет
issn 2072-0351
2072-0378
publishDate 2019-04-01
description Background: Cardiovascular autonomic neuropathy (CAN) in type 2 diabetes mellitus (T2DM), which is characterized by lesion of nerve fibers in parasympathetic and sympathetic nervous system is one of the leading causes of heart arrhythmias and an independent risk factor for cardiovascular mortality in patients with T2DM. Therefore, the problem of effective treatment of CAN is particularly relevant. Aims: To analyze the effect of long-chain polyunsaturated fatty acids (-3 PUFAs) on ambulatory blood pressure monitoring parameters in patients with T2DM and CAN. Materials and methods: 36 patients with T2DM and confirmed CAN were divided into two groups. First group received hypoglycemic therapy (n=15, control) for three months; patients in group 2 (n=21) in addition were administered 1 capsule/q.d. of -3 PUFAs for three month. Results: Treatment with -3 PUFAs led to significant decrease of the diastolic blood pressure (DBP) (p0,01), diastolic blood pressure load (p0,05), time index of DBP (p0,05) during the day; DBP (p0,05), diastolic blood pressure load (p0,05), time index of DBP (p0,05), SD DBP (p0,01) during the night (compared to the control group). Conclusions: The study showed that prescription of -3 PUFAs for three month was effective in decreasing diastolic blood pressure and its parameters among patients with T2DM and CAN.
topic diabetic cardiovascular autonomic neuropathy
polyunsaturated fatty acids
ambulatory blood pressure monitoring
url https://dia-endojournals.ru/dia/article/viewFile/9630/pdf
work_keys_str_mv AT victoriaaserhiyenko theeffectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy
AT borisnmankovsky theeffectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy
AT ludmilamserhiyenko theeffectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy
AT aleksandraserhiyenko theeffectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy
AT victoriaaserhiyenko effectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy
AT borisnmankovsky effectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy
AT ludmilamserhiyenko effectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy
AT aleksandraserhiyenko effectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy
_version_ 1721401762243411968